Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 1:32 AM
NCT ID:
NCT01573494
Eligibility Criteria:
Inclusion Criteria:
* Patients \> or = 18 years
* Patients with advanced melanoma stage IIIC (unresectable) or stage IV
* Patient not treated or not responding to chemotherapy with chemotherapy session last\> 1 month
* Patients who signed informed consent
* Patients presenting no socio-economic, psychological, familial or geographical allow proper understanding of the information leaflet of the protocol or the regular monitoring in the department of dermatology
* Patients with a life expectancy greater than 3 months
* Patients with melanoma measurable by RECIST version 1.1
* Patients with venous good for venipuncture
Exclusion Criteria:
* Patients with contraindication for treatment with chemotherapy or V600E BRAF inhibitor or ipilimumab or have conditions concomitant heavy may interfere with the treatment of metastatic melanoma
* Pregnant women or nursing
* People vulnerable detainees, adults under guardianship or curatorship, minors.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01573494
Study Brief:
Protocol Section:
NCT01573494